A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
出版年份 2017 全文链接
标题
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-03-28
DOI
10.1038/srep45554
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
- (2015) M. Dowsett et al. CLINICAL CANCER RESEARCH
- Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers
- (2015) Xiaofeng Dai et al. Scientific Reports
- Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling
- (2014) Xiaofeng Dai et al. Scientific Reports
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories
- (2013) Borbala Szekely et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen
- (2012) A. Prat et al. ANNALS OF ONCOLOGY
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
- (2012) G C Wishart et al. BRITISH JOURNAL OF CANCER
- BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
- (2012) Cécile Le Page et al. PLoS One
- A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
- (2011) Ensel Oh et al. BREAST CANCER RESEARCH AND TREATMENT
- Biologic markers determine both the risk and the timing of recurrence in breast cancer
- (2011) Laura J. Esserman et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
- (2011) Kuk Young Na et al. Journal of Breast Cancer
- Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
- (2011) Ismail Jatoi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of early molecular markers for breast cancer
- (2011) Céline Kretschmer et al. Molecular Cancer
- Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
- (2010) Yoon-La Choi et al. BMC CANCER
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population
- (2010) M. Ishitobi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death
- (2009) L. Leon Chen et al. CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis
- (2009) Mi Jeong Kwon et al. PLoS One
- BTF4/BTNA3.2 and GCS as Candidate mRNA Prognostic Markers in Epithelial Ovarian Cancer
- (2008) C. Le Page et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation